Rob Dillard

Rob Dillard is a Medical Writer at AMC Media Group.

Articles by Rob Dillard

Rob DillardMyeloma | September 18, 2024
Anito-cel showed "robust" efficacy in patients with relapsed or refractory multiple myeloma.
Rob DillardMyeloma | September 18, 2024
Myeloma in remission did not appear to affect myocardial infarction outcomes, but did affect resource utilization.
Rob DillardMyeloma | September 18, 2024
The latest data update on teclistamab in multiple myeloma continues to support strong efficacy and durable response.
Rob DillardMyeloma | September 18, 2024
The addition of daratumumab improved the performance of VRd in patients with newly diagnosed multiple myeloma.
Rob DillardMyelofibrosis | September 10, 2024
New or worsening anemia following initiation of ruxolitinib does not appear to diminish clinical benefit.
Rob DillardMyelofibrosis | September 10, 2024
Hemoglobin improvement at week 24 after transfusion is associated with improved HRQOL in myelofibrosis and anemia.
Rob DillardMyelofibrosis | September 10, 2024
Prospective analysis suggest that 4.3% of patients with ET progressed to myelofibrosis over five years of follow up.
Rob DillardMyelofibrosis | September 10, 2024
Patients with MF or ET with CALR or JAK2 mutations carried similar symptom burdens according to prospective data.
Rob DillardMyelodysplastic Syndromes | February 2, 2023
Jesus D. Gonzalez-Lugo, MD, and colleagues, presented the findings at the 2021 ASH Annual Meeting.
Rob DillardChronic Lymphocytic Leukemia | February 2, 2023
The results of two studies indicate that the mRNA COVID-19 vaccine may have attenuated efficacy in people with CLL.
Rob DillardAcute Myeloid Leukemia | February 2, 2023
Certain genetic mutations may play a role in the etiology of acute myeloid leukemia.
Rob DillardAcute Lymphoblastic Leukemia | February 2, 2023
A study evaluated the relationship between TBI and development of IPS in patients undergoing transplant for acute leukemia.
Rob DillardAcute Myeloid Leukemia | February 2, 2023
Circular RNAs may serve as an efficient and specific diagnosis tool of pediatric acute myeloid leukemia.
Rob DillardAcute Lymphoblastic Leukemia | February 2, 2023
A study was conducted to elucidate the effect of TBI parameters and peri-HCT factors on late renal dysfunction.
Rob DillardChronic Lymphocytic Leukemia | February 2, 2023
Research indicates that Hispanic patients with DLBCL have better survival than non-Hispanic White.
Rob DillardMyeloma | November 14, 2022
Researchers sought to discern the effect of COVID-19 countermeasures on treatment outcomes in a patient population receiving ...
Rob DillardAcute Lymphoblastic Leukemia | February 2, 2023
Hispanic children with ALL have worse overall survival.
Rob DillardMyeloma | November 14, 2022
Researchers of a study investigated the relationship between chronic kidney disease and multiple myeloma (MM) in a South ...
Rob DillardMyeloma | November 14, 2022
Socioeconomic status (SES) and race/ethnicity should be considered when planning multiple myeloma (MM) interventions, ...
Rob DillardMyeloma | November 14, 2022
Socioeconomic factors play a big role in multiple myeloma (MM) disparities, according to a study published in ...